Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma

被引:12
|
作者
Ortiz-Cuaran, Sandra [1 ]
Cox, David [2 ]
Villar, Stephanie [1 ]
Friesen, Marlin D. [3 ]
Durand, Geoffroy [1 ]
Chabrier, Amelie [1 ]
Khuhaprema, Thiravud [4 ]
Sangrajrang, Suleeporn [4 ]
Ognjanovic, Simona [5 ,6 ]
Groopman, John D. [3 ]
Hainaut, Pierre [1 ]
Le Calvez-Kelm, Florence [1 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
[2] Canc Res Ctr Lyon, INSERM, U1052, Lyon, France
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Natl Canc Inst, Bangkok, Thailand
[5] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[6] Int Prevent Res Inst, Lyon, France
来源
GENES CHROMOSOMES & CANCER | 2013年 / 52卷 / 10期
关键词
P53; CANCER; DNA; VARIANTS; PATHWAY; RISK;
D O I
10.1002/gcc.22086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 100 single nucleotide polymorphisms (SNP) are validated in the TP53 tumor suppressor gene. They define haplotypes, which may differ in their activities. Therefore, mutation in cancer may occur at different rates depending upon haplotypes. However, these associations may be masked by differences in mutations types and causes of mutagenesis. We have analyzed the associations between 19 SNPs spanning the TP53 locus and a single specific aflatoxin-induced TP53 mutation (R249S) in 85 in hepatocellular carcinoma cases and 132 controls from Thailand. An association with R249S mutation (P=0.007) was observed for a combination of two SNPs (rs17882227 and rs8064946) in a linkage disequilibrium block extending from upstream of exon 1 to the first half of intron 1. This domain contains two coding sequences overlapping with TP53 (WRAP53 and Hp53int1) suggesting that sequences in TP53 intron 1 encode transcripts that may modulate R249S mutation rate in HCC. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:912 / 919
页数:8
相关论文
共 50 条
  • [31] The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
    McGraw, K. L.
    Zhang, L. M.
    Rollison, D. E.
    Basiorka, A. A.
    Fulp, W.
    Rawal, B.
    Jerez, A.
    Billingsley, D. L.
    Lin, H-Y
    Kurtin, S. E.
    Yoder, S.
    Zhang, Y.
    Guinta, K.
    Mallo, M.
    Sole, F.
    Calasanz, M. J.
    Cervera, J.
    Such, E.
    Gonzalez, T.
    Nevill, T. J.
    Haferlach, T.
    Smith, A. E.
    Kulasekararaj, A.
    Mufti, G.
    Karsan, A.
    Maciejewski, J. P.
    Sokol, L.
    Epling-Burnette, P. K.
    Wei, S.
    List, A. F.
    BLOOD CANCER JOURNAL, 2015, 5 : e291 - e291
  • [32] The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
    K L McGraw
    L M Zhang
    D E Rollison
    A A Basiorka
    W Fulp
    B Rawal
    A Jerez
    D L Billingsley
    H-Y Lin
    S E Kurtin
    S Yoder
    Y Zhang
    K Guinta
    M Mallo
    F Solé
    M J Calasanz
    J Cervera
    E Such
    T González
    T J Nevill
    T Haferlach
    A E Smith
    A Kulasekararaj
    G Mufti
    A Karsan
    J P Maciejewski
    L Sokol
    P K Epling-Burnette
    S Wei
    A F List
    Blood Cancer Journal, 2015, 5 : e291 - e291
  • [33] TP53 Mutations R175H and R249S Are Rare in Indian Head and Neck Cancer Patients
    Ghosh, Arjita
    Moorthy, Anbalagan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (01) : 74 - 79
  • [34] Polymorphisms in XPD and TP53 and mutation in human lung cancer
    Mechanic, LE
    Marrogi, AJ
    Welsh, JA
    Bowman, ED
    Khan, MA
    Enewold, L
    Zheng, YL
    Chanock, S
    Shields, PG
    Harris, CC
    CARCINOGENESIS, 2005, 26 (03) : 597 - 604
  • [35] TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, China
    Szymanska, Katarzyna
    Chen, Jian-Guo
    Cui, Yan
    Gong, Yun Yun
    Turner, Paul Craig
    Villar, Stephanie
    Wild, Christopher Paul
    Parkin, Donald Maxwell
    Hainaut, Pierre
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1638 - 1643
  • [36] TP53 and gastric carcinoma: A review
    Fenoglio-Preiser, CM
    Wang, J
    Stemmermann, GN
    Noffsinger, A
    HUMAN MUTATION, 2003, 21 (03) : 258 - 270
  • [37] Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection
    Long, Jiang
    Wang, Yan
    Li, Man
    Tong, Wei-Min
    Jia, Ji-Dong
    Huang, Jian
    ONCOLOGY REPORTS, 2013, 30 (01) : 119 - 124
  • [38] Common Polymorphisms in the MDM2 and TP53 Genes and the Relationship between TP53 Mutations and Patient Outcomes in Glioblastomas
    Zawlik, Izabela
    Kita, Daisuke
    Vaccarella, Salvatore
    Mittelbronn, Michel
    Franceschi, Silvia
    Ohgaki, Hiroko
    BRAIN PATHOLOGY, 2009, 19 (02) : 188 - 194
  • [39] TP53 mutations and polymorphisms in primary myelofibrosis
    Raza, Sania
    Viswanatha, David
    Frederick, Lori
    Lasho, Terra
    Finke, Christy
    Knudson, Ryan
    Ketterling, Rhett
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 204 - 206
  • [40] TP53 mutations and Polymorphisms in Primary Myelofibrosis
    Raza, Sania S.
    Viswanatha, David
    Erickson, Lori A.
    Lasho, Terra L.
    Finke, Christy
    Knudson, Ryan A.
    Ketterling, Rhett
    Pardanani, Animesh D.
    Tefferi, Ayalew
    BLOOD, 2011, 118 (21) : 1641 - 1641